Europe's STOXX 600 ekes out gains in a start to data-heavy week; Roche slides
- Infineon plans 5-billion-euro Dresden site, raises targets
- Roche falls as Alzheimer's drug fails to meet goal
Nov 14 (Reuters) - European shares closed higher on Monday driven by positive updates from companies including Germany's Infineon and Britain's Informa, while investors positioned themselves for a slew of data including inflation and flash GDP due this week.
The pan-European STOXX 600 index (.STOXX) rose 0.1%, hovering near 11-week highs.
Informa Plc (INF.L) jumped 5.8% after the events organiser raised its full-year earnings outlook, helping London's blue-chip FTSE 100 index (.FTSE) outperform its regional peers with a 0.9% rise.
Germany's DAX (.GDAXI) gained 0.6%. Shares of Infineon (IFXGn.DE) climbed 7.8% to top the index after the chipmaker raised its long-term financial targets and said it is planning a new 5 billion-euro ($5.16 billion) factory in Dresden to expand its 300-millimetre production capacities.
The broader technology sector (.SX8P) rose 1.2%, the most among the STOXX 600 sectors.
Meanwhile, data showed Eurozone industrial output increased more than expected in September, while August production was also revised higher.
"Strong euro zone industrial output data eased concerns about the growing threat of recession," said Victoria Scholar, head of investment at Interactive Investor.
Although caution prevailed in markets after Federal Reserve policymaker Christopher Waller warned that the U.S. central bank would not "soften" its fight against inflation.
"The Fed is trying to communicate to markets that it isn't going to pivot and is going to continue with this two-way sort of communication of slowing the pace of rate hikes but that doesn't necessarily mean it will get to a lower endpoint," said Giles Coghlan, chief market analyst at HYCM in London.
European shares recorded their biggest weekly gain in nearly eight months on Friday largely driven by bets of smaller rate hikes by the Fed and easing COVID-19 curbs in China.
Still, the STOXX 600 is down 11.3% so far this year amid worries about a gloomy economic picture.
UK employment, inflation and retail sales data are on tap later this week, while the Eurozone flash third-quarter GDP estimate and October HICP inflation data among others are also scheduled.
Among other stocks, Roche Holding AG (ROG.S) slid 4% to weigh the most on the STOXX 600 after its Alzheimer's drug candidate could not be shown to markedly slow dementia progression in two drug trials.
Rheinmetall (RHMG.DE) climbed 6.7% after the military equipment manufacturer agreed to buy Spanish explosives and ammunition maker Expal Systems for an enterprise value of 1.2 billion euros ($1.24 billion).
Teleperformance (TEPRF.PA) added 6.7% after the French office support technology company said it would meet with the Colombian government after Colombia opened a probe into the firm regarding its work practices in the country.
Our Standards: The Thomson Reuters Trust Principles.